Glucose-conjugated glutenin nanoparticles for selective targeting and delivery of camptothecin into breast cancer cells

• Published in: Naunyn-Schmiedeberg's archives of pharmacology Vol. 396; no. 10; pp. 2571 - 2586
• Main Authors: Rajeshkumar, Raja Rajeswari, Pavadai, Parasuraman, Panneerselvam, Theivendren, Deepak, Venkataraman, Pandian, Sureshbabu Ram Kumar, Kabilan, Shanmugampillai Jeyarajaguru, Vellaichamy, Sivakumar, Jeyaraman, Anbu, Kumar, A. Santhana Krishna, Sundar, Krishnan, Kunjiappan, Selvaraj
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2023; Springer Nature B.V
• Subjects: Apoptosis; Biomedical and Life Sciences; Biomedicine; Breast cancer; Camptothecin; Cytotoxicity; Drug delivery; Endocytosis; Glutenin; Malignancy; Morphology; Nanoparticles; Neurosciences; Pharmacology/Toxicology; Protein transport; Reactive oxygen species; Zeta potential; Camptothecin; MCF-7 cells; Targeted drug delivery; Glucose; GLUT-1; Glutenin
• ISSN: 0028-1298; 1432-1912
• DOI: 10.1007/s00210-023-02480-y

Receptor-mediated drug delivery systems are a promising tool for targeting malignant cells to suppress/inhibit the malignancy without disturbing healthy cells. Protein-based nanocarrier systems possess numerous advantages for the delivery of variety of chemotherapeutics, including therapeutic peptides and genes. In the present work, glucose-conjugated camptothecin-loaded glutenin nanoparticles (Glu-CPT-glutenin NPs) were fabricated to deliver camptothecin to MCF-7 cells via GLUT-1 transporter protein. Initially, Glu-conjugated glutenin polymer was successfully synthesized through reductive amination reaction, and this was confirmed by FTIR and 13 C-NMR. Then, camptothecin (CPT) was loaded into Glu-conjugated glutenin polymer forming Glu-CPT-glutenin NPs. The nanoparticles were studied for their drug releasing capacity, morphological shape, size, physical nature, and zeta potential. The fabricated Glu-CPT-glutenin NPs were found to be spherical in shape and amorphous in nature with 200-nm size range and a zeta potential of − 30 mV. Furthermore, MTT assay using Glu-CPT-glutenin NPs confirmed concentration-dependent cytotoxicity against MCF-7 cells after 24-h treatment, and IC 50 was found to be 18.23 μg mL −1 . In vitro cellular uptake study demonstrated that the Glu-CPT-glutenin NPs had enhanced endocytosis and delivered CPT in MCF-7 cells. A typical apoptotic morphological change of condensed nuclei and distorted membrane bodies was found after treatment with IC 50 concentration of NPs. The released CPT from NPs also targeted mitochondria of MCF-7 cells, significantly increasing the level of reactive oxygen species and causing the damage of mitochondrial membrane integrity. These outcomes confirmed that the wheat glutenin can positively serve as a significant delivery vehicle and enhance the anticancer potential of this drug. Graphical Abstract